Sponsor Pipeline

Ambros Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Phase 3
Active Trials by Phase
Phase 3
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07210515 Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE) Complex Regional Pain Syndrome Type I Recruiting
Get alerts when Ambros Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free